|
GLSI Greenwich Lifesciences Inc 1799788 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-3,948,675.00 |
| Balance Sheet |
|
Current Assets
|
$8,876,353.00 |
|
Assets
|
$8,876,353.00 |
|
Current Liabilities
|
$5,759,396.00 |
|
Liabilities
|
$5,759,396.00 |
|
Equity
|
$3,116,957.00 |
|
Shares Out
|
14678208.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,642,244.00 |
| Market Analysis |
Market Cap
|
$224,723,364.48 |
|
Price
|
$15.31 |
|
BVPS
|
0.21 |
|
PB
|
72.90 |
|
EPS
|
-0.27 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:33 |
|
| Jul |
Aug |
Sep |
| 2026-06-01 |
-1.43 |
|
|
|
|
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-0.30 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GLSI documents filed with the SEC.
GLSI Filings
Clear
